Mira Pharmaceuticals (MIRA) Equity Ratio (2022 - 2025)

Mira Pharmaceuticals has disclosed Equity Ratio across 4 years of filings, most recently posting 0.94 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.94, up 24.57% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.94 (up 24.57% YoY), and the FY2025 annual result was 0.94, up 24.57% from the prior year.
• Equity Ratio came in at 0.94 for Q4 2025 at Mira Pharmaceuticals, down from 0.98 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.98 in Q3 2025 to a low of 0.69 in Q4 2022.
• The 4-year median for Equity Ratio is 0.84 (2024), against an average of 0.67.
• Across the five-year window, Equity Ratio jumped 227.63% in 2023 and fell 15.14% in 2024, its largest moves.
• Mira Pharmaceuticals' Equity Ratio stood at 0.69 in 2022, then soared by 227.63% to 0.89 in 2023, then dropped by 15.14% to 0.75 in 2024, then grew by 24.57% to 0.94 in 2025.
• The last three Equity Ratio figures came in at 0.94 (Q4 2025), 0.98 (Q3 2025), and 0.66 (Q2 2025), per Business Quant data.